From Molecules to Meaningful Conversations: Harnessing AI Agents for Pharma's Next Breakthrough

From Molecules to Meaningful Conversations: Harnessing AI Agents for Pharma's Next Breakthrough

Wednesday, May 21, 2025 6:55 PM to 7:20 PM · 25 min. (Africa/Abidjan)
Main Stage Theater
Track - Optimizing the US Value Chain

Information

Discover how AI-driven conversational analytics is rewriting pharma’s R&D and commercial playbook. This session reveals actionable strategies to:

  • Automate Complexity: Turn natural language queries into dynamic visualizations and calculations—no coding required—to decode molecular data, clinical trial trends, and market landscapes in seconds.
  • Predict Smarter: Leverage context-aware AI suggestions that analyze proprietary datasets to surface hidden patterns, optimize trial designs, and flag regulatory risks before they escalate.
  • Ask Better Questions: Deploy AI agents that proactively recommend critical analyses, from patient cohort stratification to drug efficacy outliers, driving faster, data-led decisions.
  • Get Insights Where You Work: Receive hyper-personalized metrics via Slack/email alerts, with AI-curated explanations of KPIs like trial enrollment rates or adverse event trends.
  • Solve Why, Not Just What: Use guided exploration to uncover root causes behind shifting metrics—whether a 20% trial dropout spike or unexpected drug interaction patterns.
  • Operationalize AI Seamlessly: Integrate smart analytics into existing workflows (CTMS, EHRs, CRM) to turn fragmented data into unified, actionable intelligence. Learn how some of the leading pharma firms are leveraging Agentic AI work to slash development timelines by 40%, boosting their ROI using AI agents.

    • Log in

    See all the content and easy-to-use features by logging in or registering!